Cytoskeleton regulator RNA is a protein that in humans is encoded by the CYTOR gene.
CYTOR plays a role in breast cancer. It regulates genes involved in the EGFR/mammalian target of rapamycin pathway and is required for cell proliferation, cell migration, and cytoskeleton organization.[1][2]
References
↑Van Grembergen, Olivier (2016). "Portraying breast cancer with long non coding RNA". Science Advances. doi:10.1126/sciadv.1600220.
Van Grembergen O, Bizet M, de Bony EJ, Calonne E, Putmans P, Brohée S, Olsen C, Guo M, Bontempi G, Sotiriou C, Defrance M, Fuks F (2016). "Portraying breast cancers with long noncoding RNAs". Sci Adv. 2 (9). doi:10.1126/sciadv.1600220. PMID27617288.
Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, Xiao B, Guo J (2014). "Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance". Tumour Biol. 35 (6): 5441–7. doi:10.1007/s13277-014-1709-3. PMID24523021.
Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, Sun B (2015). "HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma". Cell. Physiol. Biochem. 37 (2): 687–96. doi:10.1159/000430387. PMID26356260.
Yue B, Cai D, Liu C, Fang C, Yan D (2016). "Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer". Mol. Ther. 24 (12): 2064–2077. doi:10.1038/mt.2016.180. PMID27633443.
Hu HB, Jie HY, Zheng XX (2016). "Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma". Cell. Physiol. Biochem. 40 (1–2): 117–125. doi:10.1159/000452529. PMID27855375.